PRIMARY STUDY

High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain

Key Findings:  Data revealed that weight changes induced by THCV and rimonabant were in part mediated by modulation of GPR55 (notably THCV acted an agonist or an antagonist depending on the assay).

Type of Study:  Animal Study

Study Result:  Positive

Study Location(s):  United Kingdom

Year of Pub:  2020


Cannabinoids Studied:  SR-x Synthetic Cannabinoids, Tetrahydrocannabivarin (THCV)

Phytocannabinoid Source:  Unspecified

Receptors Studied:  CB1

Route of Administration:  Oral (Ingestion)



Link to study